Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Mouse Anti-Human CD4-PE/CY5.5 (RFT4)

Cat. No.:
PE/CY5.5 Anti-Human CD4 antibody for use in flow cytometry assays.
Size Price (USD) Quantity
100 tests $259.00
More Information
Clone RFT4
Isotype Mouse (BALB/c) IgG1κ
Isotype Control 0102-16
Specificity Human CD4
Alternative Names T4, Leu-3
Description CD4 is a 55 kDa type I transmembrane glycoprotein and a member of the Ig-SF of cell surface receptors. It is expressed predominantly on the “helper/inducer” subpopulation of mature T lymphocytes and on monocytes and macrophages. Domains 1 and 2 bind to MHC Class II antigens, while domains 3 and 4 may be involved in cis interactions with the CD3/TCR complex. CD4 functions as an accessory molecule in the recognition of foreign antigens in association with MHC class II antigens by T cells.
Immunogen Thymocytes and E-rosetted lymphocytes
Conjugate PE/CY5.5 (R-phycoerythrin/Cyanine 5.5)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide and a stabilizer
Clonality Monoclonal
Concentration Lot specific
Volume 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light; Do not freeze
Trademark Information Cy® is a registered trademark of Global Life Sciences Solutions Germany GmbH
Applications Flow Cytometry – Quality tested 1,7-9
Immunohistochemistry-Frozen Sections – Reported in literature 3
Immunocytochemistry – Reported in literature 4,5
Western Blot – Reported in literature 2
Separation – Reported in literature 6

RRID Number AB_2796856
Gene ID 920 (Human)
Gene ID Symbol CD4 (Human)
Gene ID Aliases CD4mut
UniProt ID P01730 (Human
UniProt Name CD4_HUMAN (Human)

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view

Need help with this product?
or call 800.722.2255
  1. 1. Sattentau QJ, Arthos J, Deen K, Hanna N, Healey D, Beverley PC, et al. Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J Exp Med. 1989;170:1319-34. (FC)
  2. 2. Eugene HS, Pierce-Paul BR, Craigo JK, Ross TM. Rhesus macaques vaccinated with consensus envelopes elicit partially protective immune responses against SHIV SF162p4 challenge. Virol J. 2013;10:102. (WB)
  3. 3. Hufert FT, van Lunzen J, Janossy G, Bertram S, Schmitz J, Haller O, et al. Germinal centre CD4+ T cells are an important site of HIV replication in vivo. AIDS. 1997;11:849-57. (IHC-FS)
  4. 4. Poulter LW, Norris A, Powers C, Condez A, Burnes H, Schmekel B, et al. T cell dominated inflammatory reactions in the bronchioles of asymptomatic asthmatics are also present in the nasal mucosa. Postgrad Med J. 1991;67:747-53. (ICC)
  5. 5. Burgess R, Hyde K, Maguire PJ, Kelsey PR, Yin JA, Geary CG. Two-colour immunoenzymatic technique using sequential staining by APAAP to evaluate two cell antigens. J Clin Pathol. 1992;45:206-9. (ICC)
  6. 6. D'Acquisto F, Paschalidis N, Raza K, Buckley CD, Flower RJ, Perretti M. Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells. Rheumatology. 2008;47:636-9. (Sep)
  7. 7. Daubenberger CA, Salomon M, Vecino W, Hübner B, Troll H, Rodriques R, et al. Functional and structural similarity of Vγ9V δ2 T cells in humans and Aotus monkeys, a primate infection model for Plasmodium falciparum malaria. J Immunol. 2001;167:6421-30. (FC)
  8. 8. Zariffard MR, Saifuddin M, Finnegan A, Spear GT. HSV type 2 infection increases HIV DNA detection in vaginal tissue of mice expressing human CD4 and CCR5. AIDS Res Hum Retroviruses. 2009;25:1157-64. (FC)
  9. 9. Roetynck S, Olotu A, Simam J, Marsh K, Stockinger B, Urban B, et al. Phenotypic and functional profiling of CD4 T cell compartment in distinct populations of healthy adults with different antigenic exposure. PLoS One. 2013;8(1):e55195. (FC)
See All References